Article
Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid.
Pharmacogenetics and genomics - 1 Dec 2015
Choi Hee Youn, Bae Kyun-Seop, Cho Sang-Heon, Ghim Jong-Lyul, Choe Sangmin, Jung Jin Ah, Jin Seok-Joon, Kim Hee-Sun, Lim Hyeong-Seok
Abstract excerpt
OBJECTIVE: The effects of various polymorphisms in cytochrome P450 (CYP) enzyme and transporter genes on the pharmacokinetics (PK) of simvastatin were evaluated in healthy Korean men. METHODS: Plasma concentration data for simvastatin and simvastatin acid were pooled from four phase I studies comprising 133 participants. The polymorphisms CYP2D6*4, CYP2D6*5, CYP2D6*14, CYP2D6*41, CYP3A5*3, CYP2C19*2, CYP2C19*3,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
